AMES TECHNOLOGY, INC.

PORTLAND, OR · Medtech · Private

AMES, an FDA-cleared non-invasive neurorehabilitation device that uses electrical stimulation to enhance motor performance and reduce sensorimotor impairment

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
PORTLAND, OR
Latest Form D
$30K, Nov 2013
Total capital
$405K
Federal grants
$225K
1 award · 2016
Rank in peer group#287 of 542
Private capital raised
$180K
2 Form D · last Nov 2013
155 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20122013201420152016FEDERAL ↑EQUITY ↓Cumulative $405K$225K1st Form D$150K2nd Form D$30K
20122013201420152016FEDERAL ↑EQUITY ↓Cumulative $405K$225K2nd Form D$30K

Latest events

  • Federal grantHealth and Human S · Phase I · Training the brain with a robotic device for balance recovery in near-frail older adults$225K
  • Private capital raisedForm D · SEC · 2nd filing$30K
  • Private capital raisedForm D · SEC · 1st filing$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Paul L. CordoResearcherExecutive Officer, DirectorLinked by $225K in grants as PI
  • Bruce H GibbinsDirectorNamed in SEC Form D filings
  • Charles H FarringtonDirectorNamed in SEC Form D filings
  • DENIS H. BURGERDirectorNamed in SEC Form D filings
  • James H RuddDirectorNamed in SEC Form D filings
  • Jim H RechDirectorNamed in SEC Form D filings
Show all 8 people
  • JOHN H. HERMANDirectorNamed in SEC Form D filings
  • ROGER L. WEYELExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • IFIT PROSTHETICS, LLCSimilar federal contract value in Medtech · null in contracts
  • SUBTLE TECHNOLOGY LLCSimilar federal contract value in Medtech · null in contracts
  • NeuroEM Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
  • OnLume Inc.Similar federal contract value in Medtech · null in contracts
  • Polyvascular CorpSimilar federal contract value in Medtech · null in contracts
  • Veriskin, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .